ArticleThe Lancet. Infectious diseases2022

Effectiveness of BNT162b2 booster after CoronaVac primary regimen in pregnant people during omicron period in Brazil.

Pilar T V Florentino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.